Market Closed -
Nyse
16:00:02 2024-06-27 EDT
|
5-day change
|
1st Jan Change
|
44.42
USD
|
+0.41%
|
|
+1.62%
|
-5.93%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,655
|
3,126
|
2,817
|
2,632
|
1,711
|
1,614
|
-
|
-
|
Enterprise Value (EV)
1 |
4,827
|
4,136
|
3,791
|
4,028
|
3,082
|
2,893
|
2,576
|
2,499
|
P/E ratio
|
20.1
x
|
16.9
x
|
24.3
x
|
12.8
x
|
-315
x
|
33.1
x
|
10.2
x
|
7.58
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.83
x
|
2.57
x
|
2.02
x
|
1.58
x
|
1.01
x
|
1.08
x
|
1.04
x
|
1.01
x
|
EV / Revenue
|
3.73
x
|
3.4
x
|
2.72
x
|
2.41
x
|
1.82
x
|
1.94
x
|
1.67
x
|
1.56
x
|
EV / EBITDA
|
12.2
x
|
10.4
x
|
8.98
x
|
8.9
x
|
7.77
x
|
7.61
x
|
5.91
x
|
5.36
x
|
EV / FCF
|
30
x
|
15.3
x
|
20
x
|
23.6
x
|
32.3
x
|
51.5
x
|
13.4
x
|
13.4
x
|
FCF Yield
|
3.33%
|
6.54%
|
4.99%
|
4.24%
|
3.09%
|
1.94%
|
7.46%
|
7.48%
|
Price to Book
|
6.89
x
|
4.9
x
|
4.18
x
|
3.76
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
41,824
|
41,279
|
39,286
|
37,372
|
36,231
|
36,329
|
-
|
-
|
Reference price
2 |
87.38
|
75.73
|
71.70
|
70.44
|
47.22
|
44.42
|
44.42
|
44.42
|
Announcement Date
|
2/3/20
|
2/10/21
|
2/23/22
|
2/27/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,293
|
1,216
|
1,392
|
1,668
|
1,692
|
1,494
|
1,545
|
1,598
|
EBITDA
1 |
396.9
|
397.9
|
422.2
|
452.6
|
396.8
|
380.1
|
436
|
466.5
|
EBIT
1 |
311.9
|
297.7
|
312.3
|
343.8
|
76.9
|
260.4
|
314.6
|
346
|
Operating Margin
|
24.12%
|
24.48%
|
22.44%
|
20.61%
|
4.54%
|
17.43%
|
20.37%
|
21.65%
|
Earnings before Tax (EBT)
1 |
227.9
|
235.1
|
162.8
|
269.6
|
-10.1
|
65.1
|
210.8
|
282
|
Net income
1 |
183.7
|
186.2
|
118.1
|
211.6
|
-5.4
|
40.33
|
162.2
|
217
|
Net margin
|
14.21%
|
15.31%
|
8.49%
|
12.68%
|
-0.32%
|
2.7%
|
10.5%
|
13.58%
|
EPS
2 |
4.350
|
4.480
|
2.950
|
5.500
|
-0.1500
|
1.340
|
4.340
|
5.860
|
Free Cash Flow
1 |
160.9
|
270.3
|
189.2
|
170.6
|
95.3
|
56.2
|
192.2
|
187
|
FCF margin
|
12.44%
|
22.23%
|
13.6%
|
10.23%
|
5.63%
|
3.76%
|
12.44%
|
11.7%
|
FCF Conversion (EBITDA)
|
40.54%
|
67.93%
|
44.81%
|
37.69%
|
24.02%
|
14.78%
|
44.09%
|
40.09%
|
FCF Conversion (Net income)
|
87.59%
|
145.17%
|
160.2%
|
80.62%
|
-
|
139.34%
|
118.48%
|
86.18%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/3/20
|
2/10/21
|
2/23/22
|
2/27/23
|
2/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
336
|
382.8
|
419.9
|
482
|
383.6
|
392.6
|
481.8
|
446
|
371.7
|
340.1
|
408
|
408.3
|
333.6
|
325.1
|
445.2
|
EBITDA
1 |
79.6
|
119
|
121.1
|
138.2
|
74.3
|
103.9
|
120.7
|
110.4
|
61.8
|
76.9
|
104.1
|
110.5
|
86.65
|
84.65
|
127
|
EBIT
1 |
51.4
|
88.3
|
91.6
|
107.3
|
44.1
|
72.8
|
69.3
|
55.2
|
-131.3
|
47.3
|
72.2
|
79.9
|
53.5
|
-
|
-
|
Operating Margin
|
15.3%
|
23.07%
|
21.81%
|
22.26%
|
11.5%
|
18.54%
|
14.38%
|
12.38%
|
-35.32%
|
13.91%
|
17.7%
|
19.57%
|
16.04%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
36.3
|
77.6
|
76.5
|
95.8
|
19.7
|
64.1
|
47.7
|
32.1
|
-154
|
-71.9
|
50.1
|
47.5
|
21.8
|
23.35
|
68.4
|
Net income
1 |
29.3
|
60.8
|
59.8
|
75.4
|
15.6
|
50.7
|
35.5
|
25.2
|
-116.8
|
-56
|
33.55
|
35.47
|
16.2
|
17.75
|
52.45
|
Net margin
|
8.72%
|
15.88%
|
14.24%
|
15.64%
|
4.07%
|
12.91%
|
7.37%
|
5.65%
|
-31.42%
|
-16.47%
|
8.22%
|
8.69%
|
4.86%
|
5.46%
|
11.78%
|
EPS
2 |
0.7400
|
1.550
|
1.540
|
1.980
|
0.4100
|
1.350
|
0.9700
|
0.6900
|
-3.230
|
-1.540
|
1.050
|
0.9900
|
0.4700
|
0.4850
|
1.425
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/23/22
|
5/4/22
|
8/2/22
|
11/2/22
|
2/27/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/21/24
|
5/1/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,172
|
1,010
|
975
|
1,396
|
1,371
|
1,279
|
962
|
885
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.953
x
|
2.538
x
|
2.308
x
|
3.084
x
|
3.456
x
|
3.366
x
|
2.207
x
|
1.897
x
|
Free Cash Flow
1 |
161
|
270
|
189
|
171
|
95.3
|
56.2
|
192
|
187
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
12.70
|
15.50
|
17.20
|
18.70
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
6.530
|
8.480
|
7.310
|
-
|
-
|
1.160
|
3.850
|
-
|
Capex
1 |
115
|
82.1
|
104
|
143
|
110
|
105
|
121
|
117
|
Capex / Sales
|
8.88%
|
6.75%
|
7.46%
|
8.54%
|
6.49%
|
7%
|
7.81%
|
7.32%
|
Announcement Date
|
2/3/20
|
2/10/21
|
2/23/22
|
2/27/23
|
2/21/24
|
-
|
-
|
-
|
Last Close Price
44.42
USD Average target price
57.6
USD Spread / Average Target +29.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.93% | 1.61B | | +5.43% | 76.68B | | -6.34% | 43.33B | | +3.96% | 33.44B | | +16.38% | 19.16B | | +8.19% | 11.43B | | -23.62% | 9.82B | | -9.46% | 9.75B | | -0.82% | 8.91B | | -1.90% | 8.73B |
Diversified Chemicals
|